|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����ɫ�� |
|
���� |
| ��������������� | |
|
��� |
|
���� |
| PubMed | |
|
Article by |
|
Article by |
����ɫ���뺹��
���, ����
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о���, �Ͼ�210042
����������֬��ĸ����ɫ���������Ƥ�������Ⱦ,һ����Ϊ�ɿ�������ɫ������,Ҳ�б���������ߵ��²���Ϊ��������ɫ�������߳���������ů��ʪ�Ļ�����,����һ�������²���Ⱦ,����ȱ�ݻ�����Ϊ�÷�������ɫ��ϸ�����е�֬�ʳɷֿ��յ���������������ݡ�Ŀǰ���ƺ���������ҩ��Ϊ��,�����������������ǹ̴���л���ڡ�
[2] Weiss R,Raabe P,Mayser P.Yeasts of the genus Malessezia:taxonomic classification and significance in (veterinary and) clinical medicine.My-coses,2000,(43 Suppl 1):69-72.
[3] Nakabayashi A,Sei Y,Guillot J.Identification of Malassezia species iso-lated from patients with seborrhoeic dermatitis,atopic dermatitis,pityriasis versicelor and normal subjects.Meal Mycol,2000,38(5):337-341.
[4] Crespe Erchiga V,Ojeda Martos A,Vera Casano A,et al.Malassezia globosa as the causative agent of pityriasis versicolor.Br J Dermatol,2000,143(4):799-803.
[5] Okuda C,ho M,Naka W,et al.Pityriasis versicolor with a unique clini-cal appearance.Med Mycol,1998,36(5):331-334.
[6] Euvrard S,Kanitakis J,Claudy A.Cutaneous complications after organ transplant.Presso Med,1999,28(33):1833-1838.
[7] Virgili A,Zampino MR,La Malfa V,et al.Prevalence of superficial der-matomycoses in 73 renal transplant recipients.Dermatology,1999,199(1):31-34.
[8] Bouassida S,Boudaya S,Ghorbel R,et al.Pityriasis versicolor in children:a retrospective study of 164 cases.Ann Dermatol Venereol,1998,125(9):581-584.
[9] Saadatzadeh MR,Ashbee HR,Ctmliffe WJ,et al.Cell-mediated immunity to the mycelial phase of Malassezia spp.in patients with pityriasis versi-color and controls.Br J Dermatol,2001,144(1):77-84
[10] Kesavan S,Waiters CE,Holland KT,et al.The effects of Malassezia on pro-inflammatory cytokine production by human peripheral blood mononu-clear cells in vitro.Med Mycol,1998,36(2):97-106.
[11] Kesuvan S,Holland KT,Ingham E.The effects of lipid extraction on the immunomodulatory activity of Malassezia species in vitro.Med Mycol,2000,38(3):239-247.
[12] Silva V,Fischman O,de Camargo ZP.Humoral immune response to Malassezia furfur in patients with pityriasis versicolor and seborrheic der-matitis.Mycopatholagia,1997,139(2):79-85.
[13] Mayser P,Wille G,Imkampe A,et al.Synthesis of fluorochromes and pigments in Malassezia furfur by use of tryptophan as the single nitrogen source.Mycoses,1998,41(7-8):265-271.
[14] Strippoli V,Piacentini A,D' Auria FD,et al.Antifungal activity of keto-conazole and other azoles against Malassezia furfur in vitro and in vivo.Infection,1997,25(5):303-306.
[15] Lange DS,Richards HM,Guamieri J,et al.Ketocenazole 2% shampoo in the treatment of tinea yersicolor:a multicenter,randomized,double-blind,placebo-centrolled trial.J Am Acad Dermatol,1998,39(6):944-950.
[16] Nenoff P,Hanstein UF.In vitro susceptibility testing of Malassezi.a furfur against rilopirox.Skin Pharmacol,1997,10(5-6):275-280.
[17] Roberts DT.Oral terbinafme (Lamisil) in the treatment of fungal infections of the skin and nails.Dermatology,1997,194 (Suppl 1):37-39.
[18] Vermeer BJ,Staats CC.The efficacy of a topical application of terbinafme 1% solution in subjects with pityriasis versicolor:a placebo-controlled study.Dermatology,1997,194 (Suppl 1):22-24.
[19] Gugnani HC,Gugnani A,Malachy O.Sulconazole in the therapy of der-matomycoses in Nigeria.Mycoses,1997,40(3-4):139-141.